Dr. Sudarshan Rajagopal, MD

Dr. Rajagopal practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Rajagopal's NPI, 1134391253, was assigned on March 28, 2008. Dr. Rajagopal holds North Carolina license 2009-01799.

Dr. Rajagopal's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Rajagopal's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Rajagopal to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajagopal practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rajagopal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rajagopal is licensed in North Carolina.

CMS data shows 422 Medicare services from Dr. Rajagopal across 8 procedure codes in 2024, for 151 Medicare patients. Medicare paid $21,680 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Rajagopal in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rajagopal's median patient age at 71, with 60% women.

In 2024, Dr. Rajagopal wrote 1,803 Medicare Part D claims for 130 patients. 47% of them were for generic drugs. CMS names the drug for 1,681 of them, across 27 drugs with 11 or more claims each, at $12,093,701 in total drug cost. In 2023, CMS named 1,412 claims across 26 drugs.

Dr. Rajagopal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rajagopal as offering telehealth.

Dmand AI links 98 papers to Dr. Rajagopal, published from 2010 to 2025. 2018 was the busiest year, with 11. The most frequent topics are Hypertension, Pulmonary, Signal Transduction and beta-Arrestins. Dr. Rajagopal has published most often in Am J Respir Crit Care Med. Dr. Rajagopal's most frequent co-authors are Robert Lefkowitz, MD, Kishan S. Parikh, MD and Yen-Rei Andrea Yu, MD, PhD.

Dmand AI links Dr. Rajagopal to 9 clinical trials, 5 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Hypertension. Bastiaan Driehuys sponsors the most, 4. Open Payments lists research payments to Dr. Rajagopal that name 1 trial.

CMS Open Payments shows 298 general payments to Dr. Rajagopal from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. United Therapeutics Corporation paid the most, $66,791. It also lists 5 research payments totaling $1,087 in 2018, naming 1 clinical trial.